GSK Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - GlaxoSmithKline PLC

Watchlist Manager

Watchlist

Price: 1 938 GBX 1.89% Market Closed

Market Cap: £78.6B

	GlaxoSmithKline PLC LSE:GSK	UK
	China Longyuan Power Group Corp Ltd HKEX:916	CN
H	Haypp Group AB (publ) STO:HAYPP	SE
F	Far East Hospitality Trust SGX:Q5T	SG
	Energy Transfer LP NYSE:ET	US
	Gates Industrial Corporation PLC NYSE:GTES	US

Profitability Summary

GlaxoSmithKline PLC's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

73%

Strong 3Y Average Gross Margin

72%

Gross Margin is Increasing

70% > 73%

Healthy Operating Margin

27%

Sustainable 3Y Average Operating Margin

26%

Operating Margin is Increasing

26% > 27%

Healthy Net Margin

18%

Sustainable 3Y Average Net Margin

17%

Declining Net Margin

50% > 18%

Exceptional Free Cash Flow Margin

15%

Strong 3Y Average Free Cash Flow Margin

14%

Free Cash Flow Margin is Increasing

9% > 15%

Exceptional ROE

36%

Exceptional 3Y Average ROE

Positive 3Y Average ROIC

18%

ROIC is Increasing

14% > 18%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.